JPS6133820B2 - - Google Patents
Info
- Publication number
- JPS6133820B2 JPS6133820B2 JP5722376A JP5722376A JPS6133820B2 JP S6133820 B2 JPS6133820 B2 JP S6133820B2 JP 5722376 A JP5722376 A JP 5722376A JP 5722376 A JP5722376 A JP 5722376A JP S6133820 B2 JPS6133820 B2 JP S6133820B2
- Authority
- JP
- Japan
- Prior art keywords
- amino
- caprolactam
- chloroform
- adduct
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 84
- BOWUOGIPSRVRSJ-UHFFFAOYSA-N 2-aminohexano-6-lactam Chemical compound NC1CCCCNC1=O BOWUOGIPSRVRSJ-UHFFFAOYSA-N 0.000 claims description 40
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000013078 crystal Substances 0.000 description 26
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 125000003277 amino group Chemical group 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 238000004817 gas chromatography Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241001550224 Apha Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- -1 α-amino-ε-caprolactam chloroform Chemical compound 0.000 description 2
- 238000006237 Beckmann rearrangement reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明はα−アミノ−ε−カプロラクタム・ク
ロロホム付加物およびその製法に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an α-amino-ε-caprolactam chloroform adduct and a method for producing the same.
α−アミノ−ε−カプロラクタムは必須アミノ
酸であるリジンの合成原料として公知であるが、
この他にもα−アミノ−ε−カプロラクタムが持
つている有機アミンとしての特性を活かして今後
多様な使途に発展してゆく可能性を有する極めて
有用な化合物である。ところが、このα−アミノ
−ε−カプロラクタムは、非常に活性の大きいア
ミノ基を有するために、空気により不純化されや
すく、安定して保存し難いという欠点や、また、
原料として用いる際の反応性が大きすぎるという
欠点があつた。 α-Amino-ε-caprolactam is known as a raw material for the synthesis of lysine, an essential amino acid.
In addition to this, α-amino-ε-caprolactam is an extremely useful compound that has the potential to be developed into a variety of other uses in the future by taking advantage of its properties as an organic amine. However, since α-amino-ε-caprolactam has an extremely active amino group, it is easily contaminated by air and has the disadvantage of being difficult to store stably.
The drawback was that the reactivity was too high when used as a raw material.
そこで、本発明者らはα−アミノ−ε−カプロ
ラクタムについて鋭意研究した結果、α−アミノ
−ε−カプロラクタムはクロロホルムと付加物を
生成し、しかも、該付加物は結晶体として単離す
ることができ、そして、上記欠点のない有用な新
規物質であること、および、その有利な製造条件
を見い出し、本発明をなすに至つたものである。 As a result of intensive research on α-amino-ε-caprolactam, the present inventors found that α-amino-ε-caprolactam forms an adduct with chloroform, and that this adduct cannot be isolated as a crystal. The inventors have discovered that the present invention is a useful new substance that does not have the above-mentioned drawbacks, and that they have found advantageous production conditions.
すなわち、本発明は、α−アミノ−ε−カプロ
ラクタム1モルにクロロホルム1モルが結合して
なる結晶状付加物、および、α−アミノ−ε−カ
プロラクタムとクロロホルムとをモル比1:(1
以上)で接触させ、次いで、30℃以下で晶析分離
することからなる上記付加物の製法から構成され
る。 That is, the present invention provides a crystalline adduct in which 1 mole of chloroform is bonded to 1 mole of α-amino-ε-caprolactam, and a crystalline adduct in which 1 mole of α-amino-ε-caprolactam and chloroform are combined in a molar ratio of 1:(1
The method for producing the above-mentioned adduct consists of contacting the adduct at 30° C. or below, followed by crystallization and separation at 30° C. or below.
本発明の結晶状付加物は、融点31℃の白色結晶
である。元素分析およびNMRスペクトルでの測
定結果によると、この付加物はα−アミノ−ε−
カプロラクタムとクロロホルムとがモル比1:1
で結合してなる物質である。また、NMRスペク
トル測定によるα−アミノ−ε−カプロラクタム
のアミノ基の化学シフト、アミノ基の水素の化学
シフト、クロロホルムの水素の化学シフトおよび
付加物におけるクロロホルムの水素の化学シフト
の値からクロロホルムの水素はα−アミノ−ε−
カプロラクタムのアミノ基に結合しているものと
推定される。 The crystalline adduct of the present invention is a white crystal with a melting point of 31°C. According to elemental analysis and NMR spectroscopy, this adduct is α-amino-ε-
Caprolactam and chloroform in a molar ratio of 1:1
It is a substance formed by bonding with. In addition, from the values of the chemical shift of the amino group of α-amino-ε-caprolactam, the chemical shift of the hydrogen of the amino group, the chemical shift of the hydrogen of chloroform, and the chemical shift of the hydrogen of chloroform in the adduct, the hydrogen of chloroform was determined by NMR spectroscopy. is α-amino-ε-
It is presumed to be bonded to the amino group of caprolactam.
本発明の付加物は30℃以下では安定であるが、
α−アミノ−ε−カプロラクタムとクロロホルム
の結合力は比較的小さいものと見られ、たとえば
この付加物を加熱することにより、容易にクロロ
ホルムが脱離し、α−アミノ−ε−カプロラクタ
ムを回収することができる。 Although the adduct of the present invention is stable below 30°C,
The binding force between α-amino-ε-caprolactam and chloroform is thought to be relatively small, and for example, by heating this adduct, chloroform can be easily desorbed and α-amino-ε-caprolactam can be recovered. can.
本発明の付加物はα−アミノ−ε−カプロラク
タムとクロロホルムを通常液相で接触させること
により、製造することができる。この場合両者を
溶解し得る溶媒か過剰のクロロホルムを使用する
のが好ましい。α−アミノ−ε−カプロラクタム
とクロロホルムの量比は生成する付加物の組成に
は影響を与えないが、付加物結晶の収率を高める
ためにはクロロホルムをα−アミノ−ε−カプロ
ラクタムに対して等モル以上用いるのが好まし
い。α−アミノ−ε−カプロラクタムとクロロホ
ルムの両者を溶解し得る溶媒としては、例えば炭
素数2以上の脂肪族アルコール類が使用できる。
α−アミノ−ε−カプロラクタムとクロロホルム
の付加物を生成するためには、クロロホルムと接
触させる際、α−アミノ−ε−カプロラクタムは
遊離の形で存在することが必要である。従つて、
系内に酸が存在する場合には、アンモニアのよう
なアルカリで中和する必要がある。一方、アンモ
ニアのようなアルカリは系内に存在しても付加物
生成に支障はない。反応温度は特に制限されない
が、α−アミノ−ε−カプロラクタムに対するク
ロロホルムの量や溶媒の使用量などによつて通常
0〜60℃の範囲で選定される。また反応時間は十
分な撹拌を行なえば数分以上でよい。 The adduct of the present invention can be produced by bringing α-amino-ε-caprolactam and chloroform into contact, usually in a liquid phase. In this case, it is preferable to use a solvent capable of dissolving both or an excess of chloroform. Although the quantitative ratio of α-amino-ε-caprolactam and chloroform does not affect the composition of the adduct produced, in order to increase the yield of adduct crystals, it is necessary to use chloroform relative to α-amino-ε-caprolactam. It is preferable to use an equimolar amount or more. As a solvent capable of dissolving both α-amino-ε-caprolactam and chloroform, for example, aliphatic alcohols having 2 or more carbon atoms can be used.
In order to produce an adduct of α-amino-ε-caprolactam and chloroform, it is necessary that the α-amino-ε-caprolactam be present in free form upon contact with chloroform. Therefore,
If an acid is present in the system, it must be neutralized with an alkali such as ammonia. On the other hand, even if an alkali such as ammonia is present in the system, it does not hinder the formation of adducts. The reaction temperature is not particularly limited, but is usually selected within the range of 0 to 60°C depending on the amount of chloroform and the amount of solvent used relative to α-amino-ε-caprolactam. Further, the reaction time may be several minutes or more if sufficient stirring is performed.
液相中に生成した本発明の付加物は通常過剰の
クロロホルムないし溶媒を留去させ、かつ系の温
度を30℃以下にすることによつて結晶として分離
することができる。効率よく付加物の分離を行な
うためには、過剰のクロロホルムまたは溶媒の量
は付加物に対する重量基準で1.5倍以下好ましく
は1倍以下にするのが良い。 The adduct of the present invention produced in the liquid phase can usually be separated as crystals by distilling off excess chloroform or solvent and lowering the temperature of the system to 30°C or less. In order to efficiently separate the adduct, the amount of excess chloroform or solvent is preferably 1.5 times or less, preferably 1 time or less, based on the weight of the adduct.
本発明の付加物は優れた結晶化特性を有し、晶
析を繰り返えすことより容易に精製することがで
きる。また上でも述べたごとく、比較的容易にク
ロロホルムを放出してα−アミノ−ε−カプロラ
クタムにすることができる。たとえば付加物を単
に65℃に加熱してもよいし、また約20mmHg程度
の減圧下におくことによつてもクロロホルムを放
出させることができる。 The adduct of the present invention has excellent crystallization properties and can be easily purified by repeated crystallization. Furthermore, as mentioned above, chloroform can be released relatively easily to form α-amino-ε-caprolactam. For example, chloroform can be released by simply heating the adduct to 65°C or by placing it under reduced pressure of about 20 mmHg.
したがつてこのような本発明の付加物の性質を
利用すればα−アミノ−ε−カプロラクタムの高
度な精製を行なうことができる。 Therefore, by utilizing the properties of the adduct of the present invention, α-amino-ε-caprolactam can be highly purified.
すなわち粗α−アミノ−ε−カプロラクタムに
クロロホルムを加えて1:1付加物を形成せし
め、これを結晶として精取した後、クロロホルム
を何らかの手段で放出させて精製されたα−アミ
ノ−ε−カプロラクタムを回収することができる
のである。α−アミノ−ε−カプロラクタムの高
度の精製はこの化合物をリジン原料として使用す
る場合に特に重要である。 That is, chloroform is added to crude α-amino-ε-caprolactam to form a 1:1 adduct, which is collected as crystals, and then chloroform is released by some means to produce purified α-amino-ε-caprolactam. can be recovered. A high degree of purification of α-amino-ε-caprolactam is particularly important when this compound is used as a lysine raw material.
本発明の付加物はまた各種のα−アミノ−ε−
カプロラクタム誘導体(たとえば防かび剤として
の効果を持つものが知られている)を製造する際
にもそのままの形で原料として使用することがで
きる。 The adducts of the present invention also include various α-amino-ε-
It can also be used as a raw material in the production of caprolactam derivatives (for example, compounds known to have antifungal effects).
本発明の付加物においては本来非常に活性の大
きいα−アミノ−ε−カプロラクタムのアミノ基
が適度に反応性を抑制された形になつており、原
料として使用する場合好都合である。またはα−
アミノ−ε−カプロラクタムは非常に活性の大き
いアミノ基を有するためにシクロヘキシルアミン
のような有機アミン類の一般的性質と同じように
空気中に長期間保存すると一部不純化して着色す
るので問題であるが、本発明の付加物はアミノ基
の活性が適度に抑制されており、保存に対しても
安定である。さににまた、融点が31℃であるので
常温で結晶として取扱えるという利点がある。 In the adduct of the present invention, the amino group of .alpha.-amino-.epsilon.-caprolactam, which is originally very active, is in a form in which the reactivity is moderately suppressed, which is advantageous when used as a raw material. or α−
Amino-ε-caprolactam has a very active amino group, so if it is stored in the air for a long period of time, it becomes partially impure and becomes colored, which is a problem, as is the case with organic amines such as cyclohexylamine. However, the adduct of the present invention has the activity of the amino group moderately suppressed and is stable upon storage. Sani also has the advantage of having a melting point of 31°C, so it can be handled as a crystal at room temperature.
以下実施例により本発明を具体的に説明する。 The present invention will be specifically explained below using Examples.
実施例 1
α−アミノ−ε−カプロラクタム12.8g(0.10
モル)とクロロホルム17.9g(0.15モル)をかき
まぜ機、還流冷却器、温度計を備えた200ml容3
つ口フラスコに仕込み湯浴で加温して内液を40℃
に維持しながら15分間かきまぜた。この後湯浴を
氷水の浴に切替え、3つ口フラスコの内液を10℃
に徐冷すると白色の結晶が析出した。3つ口フラ
スコの内液全量を取り出し、過して19.2gの結
晶を得た。Example 1 α-Amino-ε-caprolactam 12.8g (0.10g
mol) and 17.9 g (0.15 mol) of chloroform in a 200 ml volume 3 equipped with a stirrer, reflux condenser, and thermometer.
Pour into a neck flask and warm in a hot water bath to bring the internal liquid to 40℃.
Stir for 15 minutes while maintaining After this, switch the hot water bath to an ice water bath, and cool the liquid in the three-necked flask to 10°C.
When the mixture was slowly cooled to , white crystals were precipitated. The entire amount of the liquid in the three-necked flask was taken out and filtered to obtain 19.2 g of crystals.
この結晶の融点は31℃であり、ガスクロマトグ
ラフイによる分析値はα−アミノ−ε−カプロラ
クタム51.5重量%、クロロホルム48.5重量%であ
つた。この分析結果はα−アミノ−ε−カプロラ
クタムとクロロホルムがモル比1:1で結合した
場合の計算値(α−アミノ−ε−カプロラクタム
51.78重量%、クロロホルム48.22重量%)とよく
一致する。 The melting point of this crystal was 31°C, and the analysis values by gas chromatography showed that it contained 51.5% by weight of α-amino-ε-caprolactam and 48.5% by weight of chloroform. This analysis result is the calculated value when α-amino-ε-caprolactam and chloroform are combined at a molar ratio of 1:1 (α-amino-ε-caprolactam
(51.78 wt%, chloroform 48.22 wt%).
この結果の元素分析結果はC:33.83%、H:
5.18%、N:11.21%、0:6.91%、Cl:42.87%
であつた。この結果はα−アミノ−ε−カプロラ
クタムとクロロホルムがモル比1:1で結合した
場合の計算値(C:33.96%、H:5.30%、N:
11.32%、O:6.46%、Cl:42.96%)とよく一致
する。 The elemental analysis results of this result are C: 33.83%, H:
5.18%, N: 11.21%, 0: 6.91%, Cl: 42.87%
It was hot. This result is a calculated value when α-amino-ε-caprolactam and chloroform are combined at a molar ratio of 1:1 (C: 33.96%, H: 5.30%, N:
11.32%, O: 6.46%, Cl: 42.96%).
この結晶のNMRスペクトルは、α−アミノ−
ε−カプロラクタムとクロロホルムのプロトンの
比は12:1でα−アミノ−ε−カプロラクタムと
クロロホルムがモル比1:1で結合している結晶
であることを示し、アミノ基の水素の化学シフト
がδ2.1、クロロホルムの水素の化学シフトはδ
7.6を示した。この化学シフトは、α−アミノ−
ε−カプロラクタムおよびクロロホルムそれぞれ
単独のNMRスペクトルにおけるアミノ基の水素
の化学シフトδ1.5、クロロホルムの水素の化学
シフトδ7.4と相違しており、クロロホルムはα
−アミノ−ε−カプロラクタムのアミノ基に結合
している可能性を示唆している。 The NMR spectrum of this crystal is α-amino-
The proton ratio of ε-caprolactam and chloroform is 12:1, indicating that it is a crystal in which α-amino-ε-caprolactam and chloroform are bonded in a molar ratio of 1:1, and the chemical shift of the hydrogen of the amino group is δ2. .1, the chemical shift of hydrogen in chloroform is δ
It showed 7.6. This chemical shift is α-amino-
In the NMR spectra of ε-caprolactam and chloroform alone, the chemical shift of the hydrogen of the amino group is δ1.5, which is different from the chemical shift of the hydrogen of chloroform, δ7.4.
This suggests the possibility that it is bonded to the amino group of -amino-ε-caprolactam.
上で得た付加物の結晶10gを減圧デシケータに
入れ、系内を3時間10mmHgにして4.6gの白色結
晶を得た。この結晶のガスクロマトグラフイによ
るα−アミノ−ε−カプロラクタムの分析値は
99.6重量%であり、IRスペクトルはα−アミノ−
ε−カプロラクタムのスペクトルと完全に一致し
た。 10 g of crystals of the adduct obtained above were placed in a vacuum desiccator, and the system was kept at 10 mmHg for 3 hours to obtain 4.6 g of white crystals. The analysis value of α-amino-ε-caprolactam by gas chromatography of this crystal is
99.6% by weight, and the IR spectrum shows α-amino-
The spectrum completely matched that of ε-caprolactam.
実施例 2
α−アミノ−ε−カプロラクタム12.8g(0.10
モル)、クロロホルム11.9g(0.10モル)、エチル
アルコール3mlを混合し、アンモニアガスを少量
吹込んだ後、実施例1の3つ口フラスコに仕込
み、25℃で30分間かきまぜた。次に内液を5℃に
冷却し、全液を過して18.7gの白色結晶を得
た。Example 2 α-amino-ε-caprolactam 12.8g (0.10
), 11.9 g (0.10 mole) of chloroform, and 3 ml of ethyl alcohol were mixed, and after blowing in a small amount of ammonia gas, the mixture was charged into the three-necked flask of Example 1 and stirred at 25° C. for 30 minutes. Next, the internal solution was cooled to 5° C., and the entire solution was filtered to obtain 18.7 g of white crystals.
この結晶の融点は31℃で、ガスクロマトグラフ
イの分析結果はα−アミノ−ε−カプロラクタム
51.6重量%、クロロホルム48.4重量%であつた。
またNMRスペクトルは実施例1で得た結晶と同
一であつた。 The melting point of this crystal is 31℃, and the gas chromatography analysis results show that it is α-amino-ε-caprolactam.
51.6% by weight, and 48.4% by weight of chloroform.
Moreover, the NMR spectrum was the same as that of the crystal obtained in Example 1.
実施例 3
実施例1で、生成物として得られたα−アミノ
−ε−カプロラクタムとクロロホルムの1:1結
晶状付加物(白色結晶)25gとα−アミノ−ε−
カプロラクタム(白色結晶)25gとをそれぞれサ
ンプルビンにて室温下30日間保管した。α−アミ
ノ−ε−カプロラクタムとクロロホルムの1:1
結晶状付加物は白色結晶のままであつたが(50%
水溶液のAPHA=100)、α−アミノ−ε−カプロ
ラクタムは黄色に変色していた(50%水溶液の
APHA=3000)。Example 3 25 g of the 1:1 crystalline adduct (white crystals) of α-amino-ε-caprolactam and chloroform obtained as the product in Example 1 and α-amino-ε-
25 g of caprolactam (white crystals) were each stored in a sample bottle at room temperature for 30 days. α-Amino-ε-caprolactam and chloroform 1:1
The crystalline adduct remained as white crystals (50%
APHA in aqueous solution = 100), and α-amino-ε-caprolactam turned yellow (in 50% aqueous solution).
APHA=3000).
実施例 4
α−アミノシクロヘキサノンオキシムを100%
硫酸中でベツクマン転位して得られた粗CLA
(純度95.2%)15gを200ml三ツ口フラスコに入
れ、クロロホルム15mlを加えて30℃で溶解させ
た。この溶液を0℃に保ちながら30分かきまぜる
と結晶が析出した。得られたスラリを遠心分離機
を用いて過し、白色結晶19.5gを得た。この結
晶の組成をガスクロマトグラフイーによつて求め
たところα−アミノ−ε−カプロラクタム50.8
%、クロロホルム49.2%であつた。この結晶15.0
gを水15mlに溶解し、得られた水層を減圧下に濃
縮乾固して結晶7.6gを得た。この結晶中のCLA
純度をガスクロマトグラフイーによつて求めたと
ころ99.7%であつた。Example 4 100% α-aminocyclohexanone oxime
Crude CLA obtained by Beckmann rearrangement in sulfuric acid
(Purity 95.2%) 15 g was placed in a 200 ml three-necked flask, 15 ml of chloroform was added, and the mixture was dissolved at 30°C. When this solution was stirred for 30 minutes while being kept at 0°C, crystals were precipitated. The resulting slurry was filtered using a centrifuge to obtain 19.5 g of white crystals. The composition of this crystal was determined by gas chromatography and was found to be α-amino-ε-caprolactam: 50.8
%, and chloroform 49.2%. This crystal 15.0
g was dissolved in 15 ml of water, and the resulting aqueous layer was concentrated to dryness under reduced pressure to obtain 7.6 g of crystals. CLA in this crystal
The purity was determined by gas chromatography and was 99.7%.
Claims (1)
ロロホルム1モルが結合してなる結晶状付加物。 2 α−アミノ−ε−カプロラクタムとクロロホ
ルムとをモル比1:(1以上)で接触させ、次い
で、30℃以下で晶析分離することを特徴とするα
−アミノ−ε−カプロラクタム・クロロホルム結
晶状付加物の製法。[Claims] 1. A crystalline adduct consisting of 1 mole of chloroform bound to 1 mole of α-amino-ε-caprolactam. 2 α-Amino-ε-caprolactam and chloroform are brought into contact with each other at a molar ratio of 1: (1 or more), and then crystallized and separated at 30°C or lower.
-Production method of amino-ε-caprolactam/chloroform crystalline adduct.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5722376A JPS52142088A (en) | 1976-05-20 | 1976-05-20 | Addition compound of alpha-amino-epsilon-caprolactam |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5722376A JPS52142088A (en) | 1976-05-20 | 1976-05-20 | Addition compound of alpha-amino-epsilon-caprolactam |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52142088A JPS52142088A (en) | 1977-11-26 |
| JPS6133820B2 true JPS6133820B2 (en) | 1986-08-04 |
Family
ID=13049521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5722376A Granted JPS52142088A (en) | 1976-05-20 | 1976-05-20 | Addition compound of alpha-amino-epsilon-caprolactam |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS52142088A (en) |
-
1976
- 1976-05-20 JP JP5722376A patent/JPS52142088A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52142088A (en) | 1977-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kappe et al. | Dipivaloylketene and its dimers.[2+ 4] Versus [2+ 2] cycloaddition reactions of. alpha.-oxo ketenes | |
| AU611235B2 (en) | Process for preparing bis(3,5-dioxpiperazinyl) alkanes or alkenes | |
| JPS6133820B2 (en) | ||
| CA1055046A (en) | Preparation of .epsilon.(.gamma.glutamyl)-lysine | |
| JPH0742269B2 (en) | 4-Alkoxy-3-pyrrolin-2-one-1-yl-acetic acid alkyl ester and process for producing the same | |
| US4058563A (en) | Novel schiff bases | |
| JPH04504405A (en) | Cyanodienes, halopyridines, intermediates and their production methods | |
| US3401194A (en) | Process for the resolution of stereoisomers from racemic 1-hydroxy-2-amino butane | |
| US3641003A (en) | Method of preparing an alpha-amino-omega-lactam | |
| NO752972L (en) | ||
| JP3046258B2 (en) | Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
| JP3640319B2 (en) | Method for producing benzamide derivative | |
| US4010160A (en) | Process for the manufacture of 1,3-bis-(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine | |
| CN105037160A (en) | A kind of method for preparing vitamin B1 intermediate | |
| RU2227141C2 (en) | Method for preparing benzylamine | |
| US2955109A (en) | Process for the production of | |
| HU196385B (en) | Process for producing nizatidine | |
| JPS6133819B2 (en) | ||
| US5998614A (en) | Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process | |
| JP2708552B2 (en) | Purification method of aliphatic triamine compound | |
| KR870000203B1 (en) | A process for preparing 9-carbamoyl fluorene derivatives | |
| JP2815438B2 (en) | Purification method of 1,2-bis (nicotinamide) propane | |
| US4048169A (en) | 1,3-Bis-(β-ethylhexyl)-5-nitro-5-methyl-hexahydropyrimidine-naphthalene-1,5-disulphonate | |
| JPS5962559A (en) | Manufacture of pure diacetonitrile | |
| JP2696727B2 (en) | Method for producing dinitroazobenzene |